COVID-19 Impact on Rare Disease Patients and Manufacturers

Protective Antibody Therapy: Preventing Future COVID-19 Outbreaks

Launch Costs—Spend Wisely: Analysis by Order of Entry

The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19

Biopharma Sales Resilience through Economic Recession

The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed?

Rapid Responders: How Innovative Technologies are Accelerating Development of New Vaccines

Launch Costs—Spend Wisely: Pre-Launch and Post-Launch Analysis

Key Trends and Developments in the Chinese Oncology Market

ATTD 2020 – Transforming Diabetes Care Through Technology

Overcoming Challenges to Realize the Promise of Genetic Medicine

2019 Biopharma Year in Review

Australian Biotechs and Medtechs: Look to the East

Health Advances Presentation at AMCP Nexus: Costs of Mandating Blister Packaging for Opioids

Reflections on #Mesa19

Key Takeaways from ESMO 2019

The Cost of Launch

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

The Top 4 Attributes of a Successful Launch Plan

Orphan Drug Development – What are the Real Costs?

Health Advances Blog

Category: BioPharma

COVID-19 Impact on Rare Disease Patients and Manufacturers

Protective Antibody Therapy: Preventing Future COVID-19 Outbreaks

Launch Costs—Spend Wisely: Analysis by Order of Entry

The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19

Biopharma Sales Resilience through Economic Recession

The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed?

Rapid Responders: How Innovative Technologies are Accelerating Development of New Vaccines

Launch Costs—Spend Wisely: Pre-Launch and Post-Launch Analysis

Key Trends and Developments in the Chinese Oncology Market

ATTD 2020 – Transforming Diabetes Care Through Technology

Overcoming Challenges to Realize the Promise of Genetic Medicine

2019 Biopharma Year in Review

Australian Biotechs and Medtechs: Look to the East

Health Advances Presentation at AMCP Nexus: Costs of Mandating Blister Packaging for Opioids

Reflections on #Mesa19

Key Takeaways from ESMO 2019

The Cost of Launch

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

The Top 4 Attributes of a Successful Launch Plan

Orphan Drug Development – What are the Real Costs?